ArticleCureus2026

Checkpoint Inhibitor-Treated Merkel Cell Carcinoma With Cytokeratin 20 (CK20)-Negative Metastatic Immunophenotypic Divergence: Diagnostic and Therapeutic Implications.

Diego Berlingeri Collazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.